13th Dec 2007 16:30
Dechra Pharmaceuticals PLC13 December 2007 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY ORINDIRECTLY, IN OR INTO, THE UNITED STATES, CANADA, JAPAN, MALAYSIA, NEW ZEALAND,SOUTH AFRICA OR AUSTRALIA OR INTO ANY JURISDICTION WHERE TO DO SO WOULD BREACHANY APPLICABLE LAW. Date: Thursday, 13 December 2007 FOR IMMEDIATE RELEASE Dechra Pharmaceuticals PLC ("Dechra") PUBLICATION OF PROSPECTUS Further to the announcement made yesterday, Dechra announces that theProspectus, in connection with the acquisition of VetXX Holding A/S and Placingand Open Offer of 11,624,544 New Ordinary Shares at 303 pence per share on an 11for 50 basis to raise approximately £35 million (before expenses), is beingposted today. Dechra shareholders (subject to certain exceptions) will be mailed theProspectus (which includes notice of an Extraordinary General Meeting to be heldat 10:30 a.m. on 8 January 2008), an application form (for Dechra shareholdersholding shares in certificated form only) in connection with the acquisition andPlacing and Open Offer and a Form of Proxy in respect of the ExtraordinaryGeneral Meeting. Copies of the Prospectus and Form of Proxy will be available in due course fromthe Company's website at www.dechra.com and will be available for inspectionduring normal business hours on Monday to Friday each week (public holidaysexcepted) from and including the date of publication of the Prospectus until 8January 2008, at the registered office of Dechra at Dechra House, JamageIndustrial Estate, Talke Pits, Stoke-on-Trent, ST7 1XW. Copies of the Prospectuswill be made available free of charge upon request. In addition, the Prospectus and Form of Proxy will shortly be available forinspection at the UK Listing Authority's Document Viewing Facility at theFinancial Services Authority, 25 North Colonnade, Canary Wharf, London, E14 5HS. Contacts:Dechra Pharmaceuticals PLC Tel: +44 (0) 1782 771 100Ian Page, Chief ExecutiveSimon Evans, Group Finance Director Dresdner Kleinwort Limited(Joint financial adviser, Sponsor Tel: +44 (0) 207 623 8000and Broker to Dechra)Jonathan Roe, Managing DirectorChristian Littlewood, DirectorChris Treneman, Managing Director NM Rothschild Limited(Joint financial adviser to Dechra) Tel: +44 (0) 2072 80 5000Lynn Drummond, Managing Director Citigate Dewe Rogerson (PR advisers) Tel: +44 (0) 121 455 8370Fiona Tooley, Director Dresdner Kleinwort Limited, which is authorised and regulated by the FinancialServices Authority, is acting as financial adviser, sponsor and broker to Dechraand for no-one else in connection with the contents of this announcement andwill not be responsible to anyone other than Dechra for providing theprotections afforded to clients of Dresdner Kleinwort Limited, or for affordingadvice in relation to the contents of this announcement or any matters referredto herein. N M Rothschild & Sons Limited, which is authorised and regulated by theFinancial Services Authority in the United Kingdom, is acting as financialadviser to Dechra and no one else in relation to the transaction and will not beresponsible to anyone other than Dechra for providing the protections affordedto clients of N M Rothschild & Sons Limited nor for providing advice in relationto the proposed transaction. This announcement does not constitute an offer to sell or the solicitation of anoffer to acquire or subscribe for New Ordinary Shares and/or to take up any entitlements. The offer to acquire New Ordinary Shares pursuant to the proposed Open Offer will be made solely on the basis of the information contained in theProspectus to be published in connection with the proposed Open Offer. The information contained in this announcement is not for release, publicationor distribution to persons in the United States, Canada, Japan, Malaysia,New Zealand, South Africa or Australia or in any jurisdiction where to do so would breach any applicable law.This announcement is not an offer of securities forsale in, into or from the United States, Canada, Japan, Malaysia, New Zealand,South Africa or Australia. The New Ordinary Shares have not been and will not beregistered under the US Securities Act of 1933 (as amended) or under any relevantsecurities laws of any state or other jurisdiction of the United States, and willnot qualify for distribution under any of the relevant securities laws ofCanada, Japan, Malaysia, New Zealand, South Africa or Australia. Accordingly,the New Ordinary Shares may not be offered, sold, taken up, exercised, resold,renounced, transferred or delivered, directly or indirectly, within theUnited States (absent registration or an applicable exemption from registration) or within Canada, Japan, Malaysia, New Zealand, South Africa or Australia. The availability of the Placing and Open Offer to persons who are not residentin the United Kingdom may be affected by the laws of the relevant jurisdictions in which they are located. Persons who are not resident in the United Kingdom should inform themselves of, and observe, any applicable requirements. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
DPH.L